// App-Quantinova.ai

: Recombinant Factor VII Activating Protease (FSAP) Decreases Infarct Volume and Improves Neurological Outcome in two Different Mouse Models of Ischemic Stroke

Researchers

Presenter

  • J.Y. Kim

Principal Investigators

  • D. Manna

  • S.M. Kanse

Medical Centers

  • University of Oslo, Institute of Basic Medical Sciences, Department of Molecular Medicine, Oslo, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • Thymidylate synthase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved